FDA approves generic form of Requip
I had a roommate in college that had what we called "jimmy legs." She didn't know what was wrong, but as soon as she'd lay down to sleep her legs would start to feel "creepy crawly" (her words) and the next thing you'd know she'd be jerking and shaking her legs -- sometimes on purpose, sometimes not. We used to laugh it off, but I know it was really uncomfortable for her. And I know that, since she didn't know what was really going on, it was frightening for her, too.Though I can't say for sure, my guess is that my roommate had restless leg syndrome (RLS). RLS is a neurological condition that affects up to 10% of the US population. RLS patients feel uncomfortable sensations and an overwhelming urge to move their legs. Symptoms become worse during rest -- particularly when lying down -- and are put at bay by movement.
GlaxoSmithKline's Requip medication has been a premiere treatment for mild to moderate RLS. The FDA just approved a generic form of Requip. The medication is also approved to treat symptoms of Parkinson's Disease.
RLS, better known as Restless Leg Syndrome, is a neurological disorder that causes people to have a strong urge to move their legs. Though it seems like just about every kid on the planet suffers from this disorder, it's typically a problem faced by older adults. 
Do you struggle at night with legs that want to keep moving, even though it's time to sleep? You may struggle from Restless Leg Syndrome (RLS). Until recently, there wasn't unanimous agreement over whether the condition had a physical or psychological basis, or if it was even real. But recent research has found
"Restless Legs Syndrome," or RLS, has only recently become a more widely recognized disorder -- most people have seen the commercials on TV and ads in magazines by now. But new research shows that people who suffer from RLS may have more to worry about than just escaping that creepy-crawly feeling in their legs: they could be at 











